BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6470484)

  • 1. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response.
    McKenzie SJ; Halsey JF
    J Immunol; 1984 Oct; 133(4):1818-24. PubMed ID: 6470484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of an enteric Ig-response against ovalbumin and stimulation of the response by cholera toxin and its B-subunit in mice.
    Bianchi AT; Zwart RJ; Van der Heijden PJ
    Reg Immunol; 1990-1991; 3(3):131-8. PubMed ID: 2098068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice.
    Van der Heijden PJ; Bianchi AT; Dol M; Pals JW; Stok W; Bokhout BA
    Immunology; 1991 Jan; 72(1):89-93. PubMed ID: 1705237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.
    Shukla A; Katare OP; Singh B; Vyas SP
    Int J Pharm; 2010 Jan; 385(1-2):47-52. PubMed ID: 19835938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.
    Matoba N; Geyer BC; Kilbourne J; Alfsen A; Bomsel M; Mor TS
    Vaccine; 2006 Jun; 24(23):5047-55. PubMed ID: 16621185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-beta 1.
    Kim PH; Eckmann L; Lee WJ; Han W; Kagnoff MF
    J Immunol; 1998 Feb; 160(3):1198-203. PubMed ID: 9570534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective induction of mucosal immune responses to 2-acetylaminofluorene.
    Silbart LK; McAleer F; Rasmussen MV; Goslinoski L; Keren DF; Finley A; Van Kruiningen HJ; Winchell JM
    Anticancer Res; 1996; 16(2):651-60. PubMed ID: 8687111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological tools for the assessment of both humoral and cellular immune responses in Foxes (Vulpes vulpes) using ovalbumin and cholera toxin B as an antigenic model.
    Rolland-Turner M; Farre G; Muller D; Rouet N; Boue F
    Vaccine; 2004 Oct; 22(31-32):4163-72. PubMed ID: 15474706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentabody-mediated antigen delivery induces antigen-specific mucosal immune response.
    Li S; Zheng W; Kuolee R; Hirama T; Henry M; Makvandi-Nejad S; Fjällman T; Chen W; Zhang J
    Mol Immunol; 2009 May; 46(8-9):1718-26. PubMed ID: 19269688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.
    Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C
    J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
    Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
    Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of local and systemic immune responses after vaginal immunization with recombinant cholera toxin B subunit in humans.
    Wassen L; Jertborn M
    Clin Diagn Lab Immunol; 2005 Mar; 12(3):447-52. PubMed ID: 15753258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
    Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S
    Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.
    George Chandy A; Hultkrantz S; Raghavan S; Czerkinsky C; Lebens M; Telemo E; Holmgren J
    Immunology; 2006 Jul; 118(3):311-20. PubMed ID: 16827892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin.
    Snider DP; Marshall JS; Perdue MH; Liang H
    J Immunol; 1994 Jul; 153(2):647-57. PubMed ID: 8021502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of natural and recombinant cholera toxin B subunit as stimulatory factors in intranasal immunization.
    de Geus B; Dol-Bosman M; Scholten JW; Stok W; Bianchi A
    Vaccine; 1997 Jul; 15(10):1110-3. PubMed ID: 9269054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.